e-learning
resources
European Respiratory Review
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
Laurent Savale, Christophe Guignabert, Jason Weatherald, Marc Humbert
Source:
Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018
Journal Issue:
June
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laurent Savale, Christophe Guignabert, Jason Weatherald, Marc Humbert. Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era. Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pulmonary arterial hypertension: combination therapy in the modern management era
Source: Eur Respir Rev 2010 19: 348-349
Year: 2010
Facing a new era: how does the pandemic change sleep medicine and practice?
Source: Sleep and Breathing Conference 2021
Year: 2021
Precision medicine in COPD: where are we and where do we need to go?
Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018
Year: 2018
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021
Precision medicine in airway diseases: moving to clinical practice
Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017
Year: 2017
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Epigenetics and pulmonary diseases in the horizon of precision medicine: a review
Source: Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020
Year: 2021
Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
Source: Eur Respir J, 53 (6) 1900583; 10.1183/13993003.00583-2019
Year: 2019
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017
Year: 2017
The new era of diagnostics: will it ever start?
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019
Precision medicine in tuberculosis treatment – a role for pharmacogenetics?
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
Source: Eur Respir J 2012; 40: 1304-1305
Year: 2012
Medical therapy for COPD: lessons from the real world
Source: Eur Respir J 2002; 20: 797-798
Year: 2002
Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers
Source: Eur Respir J 2005; 25: 397-399
Year: 2005
Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016
Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs
Source: Eur Respir Rev 2009; 18: 18-23
Year: 2009
Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet?
Source: Eur Respir Rev 2014; 23: 458-468
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept